Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by countryWhat for?
by topic- Cartels and collusion €22.4m 83 % · 3 cases
- Abuse of market power €4.67m 17 % · 1 case
- no topic €52,097 0 % · 1 case
Who?
by company- Medirex s. r. o.; KLINICKÁ BIOCHÉMIA s.r.o.; Unilabs Slovensko, s. r. o.; synlab slovakia s. r. o.; Asociácia laboratórií €14.6m 54 % · 1 case
- PHOENIX Zdravotnícke zásobovanie, a.s.; TRANSMEDIC SLOVAKIA, s.r.o. (in Konkurs) €7.8m 29 % · 1 case
- Doctolib €4.67m 17 % · 1 case
- Самостоятелна медико-диагностична лаборатория „Лина“ ЕООД €52,097 0 % · 1 case
- Veterinarska zbornica Slovenije €43,000 0 % · 1 case
When?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 1 | €43,000 |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 0 | — |
| Q1 2025 | 0 | — |
| Q2 2025 | 0 | — |
| Q3 2025 | 0 | — |
| Q4 2025 | 1 | €4.67m |
| Q1 2026 | 1 | €7.8m |
| Q2 2026 | 2 | €14.6m |
| Q3 2026 | 0 | — |
5 cases
25 Jun 2026 Самостоятелна медико-диагностична лаборатория „Лина“ ЕООДLaboratory Lina lures customers with free blood tests – 52,097 EUR for unfair competition €52,097
On application by its competitor Ramus, the Комисия за защита на конкуренцията (Bulgarian Commission for the Protection of Competition, KZK) established that the laboratory had offered packages of medical laboratory tests free of charge nationwide over extended periods (only against a fee of 2 leva for taking blood) – conduct shown by no other market participant outside joint campaigns. It found an infringement of the general clause of unfair competition law (Art. 29 ZZK – Bulgarian Protection of Competition Act) and imposed 0.3% of 2024 turnover, i.e. 52,096.55 EUR. Appeals have been lodged against the decision.
Permanent free offers to win customers can be unfair if they deviate significantly from market practice and drive out competitors.
- Authority / court
- Комисия за защита на конкуренцията (КЗК, Bulgarische Wettbewerbskommission)
- Area of law
- Competition law
- Legal basis
- Art. 29 ZZK (Generalklausel unlauterer Wettbewerb)
- Action
- Fine
- Status of proceedings
- under appeal
- Sector
- Healthcare
- Published
- 2 Jul 2026
- КЗК Публичен електронен регистър – Производство (Решение № 591 от 25.06.2026; Volltext als PDF im Register) Official register or notice
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
17 Apr 2026 Medirex s. r. o.; KLINICKÁ BIOCHÉMIA s.r.o.; Unilabs Slovensko, s. r. o.; synlab slovakia s. r. o.; Asociácia laboratóriíLaboratory cartel: 14.6 million EUR and procurement bans against diagnostic laboratories €14.6m
Four laboratories and their association coordinated negotiations on prices with health insurers, coordinated in tenders, exchanged sensitive information and allocated customers. At first instance, the Protimonopolný úrad Slovenskej republiky (Antimonopoly Office of the Slovak Republic, PMÚ SR) imposed 14,551,800 EUR and three-year procurement bans; Unilabs received a substantially reduced fine as leniency applicant and under a settlement.
Common negotiating positions towards payers via an association are a cartel – association meetings need minutes and a review of the agenda.
Information exchange among competitors and association work
- Authority / court
- Protimonopolný úrad Slovenskej republiky (PMÚ SR)
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Slowakisches Wettbewerbsschutzgesetz (Kartellverbot)
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Healthcare
- Culpability
- intentional
- Mitigating circumstances
- Unilabs: leniency reduction (50%) and settlement (a further 30%).
- Published
- 12 May 2026
- KARTELY: PMÚ odhalil kartel laboratórií a uložil pokuty takmer 15 miliónov eur Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
20 Jan 2026 PHOENIX Zdravotnícke zásobovanie, a.s.; TRANSMEDIC SLOVAKIA, s.r.o. (in Konkurs)Pharmaceutical cartel uncovered thanks to whistleblower: 7.8 million EUR against PHOENIX and TRANSMEDIC €7.8m
The two companies colluded in tenders of the General Health Insurance Company for the supply of medicines (2017–2020). For the first time, a cartel was uncovered on the basis of information from a whistleblower; the Protimonopolný úrad Slovenskej republiky (Antimonopoly Office of the Slovak Republic, PMÚ SR) imposed 7,595,200 EUR and a one-year procurement ban on PHOENIX and 201,800 EUR and a three-year procurement ban on TRANSMEDIC (first instance).
Whistleblowers receive a reward in Slovakia – internal reporting channels should be faster than the route to the authority.
Bid rigging in public tenders; whistleblowing channels
- Authority / court
- Protimonopolný úrad Slovenskej republiky (PMÚ SR)
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Slowakisches Wettbewerbsschutzgesetz (Submissionsabsprache)
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Healthcare
- Culpability
- intentional
- Mitigating circumstances
- PHOENIX: settlement with a 30% fine reduction and a shortened procurement ban.
- Published
- 24 Feb 2026
- KARTELY: PMÚ aj vďaka whistleblowerovi odhalil kartel v dodávkach liekov a uložil pokuty takmer 7,8 milióna eur Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
6 Nov 2025 DoctolibFrance: 4.665 million EUR against Doctolib for abuse in doctor appointment booking €4.67m
Doctolib tied doctors with exclusivity clauses, bundled telemedicine with the appointment booking subscription and in 2018 acquired its main competitor MonDocteur in order to eliminate it (decision 25-D-06). Fines: 4.615 million EUR for exclusivity and tying, 50,000 EUR for the acquisition.
Platforms with high market shares should have exclusivity clauses, bundled offers and acquisitions of rivals reviewed under competition law.
- Authority / court
- Autorité de la concurrence
- Area of law
- Competition law · Abuse of market power
- Legal basis
- Art. 102 AEUV, Art. L.420-2 Code de commerce
- Action
- Fine
- Status of proceedings
- under appeal
- Sector
- Healthcare
- Culpability
- intentional
- Published
- 6 Nov 2025
- L'Autorité de la concurrence sanctionne Doctolib à hauteur de 4 665 000 euros Press release of an authority
- Décision 25-D-06 relative à des pratiques mises en œuvre dans le secteur de la prise de rendez-vous médicaux en ligne Decision of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
20 Dec 2023 Veterinarska zbornica SlovenijeVeterinary chamber: 43,000 EUR for ban on discounts and advertising €43,000
Since 2015, the chamber’s professional code had prohibited its members from offering services below list price, at a discount or free of charge and from advertising prices and promotions – including online. As the first decision under the new act and in the first settlement procedure, the Javna agencija Republike Slovenije za varstvo konkurence (Slovenian Competition Protection Agency, AVK) imposed 43,000 EUR.
Professional codes of chambers are decisions of associations of undertakings – price and advertising bans in them infringe competition law.
- Authority / court
- Javna agencija Republike Slovenije za varstvo konkurence (AVK)
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Art. 5 ZPOmK-2, Art. 101 AEUV (3062-13/2019)
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Healthcare
- Mitigating circumstances
- Settlement with acknowledgement of responsibility.
- Published
- 22 Jan 2024
- Agencija je izdala prvo odločbo na podlagi vloge za poravnavo Press release of an authority
- AVK – Odločitve agencije Enforcement database of an authority
Checked against the official source on 25 Sep 2026 · Direct link